Connect with us

Hi, what are you looking for?


Lush Prize aims to stop animal testing

LUSH is a beauty brand that prides itself on being cruelty-free by not testing its products on animals, and now it is giving prizes to anyone with ideas on how to stop the practice. This is because, as a company release says, “Every year, it is estimated that more than 115 million animals are used in testing laboratories around the world.”

Earlier this month, Lush awarded the £250,000 Lush Prize (P16,022,500 at an exchange rate of P64.09 = £1), the largest prize fund in the non-animal testing sector. There are nine winning projects, organizations, and scientists from seven countries, as well as a winner of the Andrew Tyler Award. The winners share the total prize fund.

Several projects won for finding ways of testing and assessing chemicals and molecules without having to use animals in the process. The MIE Atlas Team from Cambridge University/Unilever in the UK, presented a study called “In Silico Models to Predict Human Molecular Initiating Events.” Edoardo Carnesecchi, from Utrecht University’s Institute for Risk Assessment Sciences (IRAS) in the Netherlands won for an innovative software platform to assess chemical mixtures’ toxicity and exposure, while Domenico Gadaleta from the Computational Toxicology Unit — Mario Negri Institute for Pharmacological Research in Italy won for the study “Screening Based on Structure-Activity Relationships Predicting Molecular Initiating Events of Neurotoxicity.”

Other projects won for lobbying, public awareness, and training. The Environment and Animal Society of Taiwan (EAST), won for a lobbying project which aims to erase mandatory animal testing requirements and prioritising non-animal testing methods in the chemical registration process. Meanwhile, SOKO Tierschutz in Germany won for an undercover investigation at the Laboratory of Pharmacology and Toxicology in Mienenbuettel, Germany. Helpathon from the Netherlands won for its “innovative brainstorming sessions to help scientists who currently use animals explore new approaches,” according to the Lush Prize Instagram account.

The rest of the winning projects took a look at biology. Nadine Dreser from the University of Konstanz, Germany won for a project about early neurodevelopmental disturbances during sensitive periods of stem cell differentiation. Dr. Johana Nyffeler, from the US Environmental Protection Agency, presented a study on “High-throughput phenotypic profiling of human neural progenitor cells to identify putative modes-of-action of developmental neurotoxicants.” Dr. Yuan Pang from Tsinghua University, China won for the project “Construction of advanced in-vitro tissue models based on 3D bioprinting and their application in drug discovery and toxicity tests.”

Andrew Rowan, PhD took home the Andrew Tyler Award, a nonfinancial prize, for oustanding contributions to ending animal testing. Mr. Rowan is President of Wellbeing International, and was the former CEO of Humane Society International. He has also served on the committees of several animal protection groups, including the World Society for the Protection of Animals.

“The judges were particularly excited by the fact that this year’s shortlist contained a new wave of projects which were modelling the cellular pathways of toxic molecules in their datasets. This combination of 21st century technologies showed perhaps the greatest promise yet for a widespread replacement of older and less reliable animal models on a global scale,” said Rob Harrison, Lush Prize Director.

In the Philippines, Lush is exclusively distributed by Stores Specialists, Inc. — JL Garcia

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!



WASHINGTON D.C. — The United States is seeking to form a coalition of countries to drive negotiations on a global plastic pollution treaty, weeks...


By Diego Gabriel C. Robles  THE WORLD BANK (WB) upgraded its growth forecast for the Philippines for this year and 2023, citing an “accommodative”...


THE PHILIPPINE auto industry’s sales recovery will likely be derailed if a measure reimposing excise taxes on pickup trucks is signed into law, according...


THE BANGKO SENTRAL ng Pilipinas (BSP) may deliver a second off-cycle rate hike in early November when the US Federal Reserve is expected to...


THE ASIAN Development Bank (ADB) is planning to allocate at least $14 billion for a program aimed at easing a food crisis in the...


With the reversal of the 1.25% rise in National Insurance Contributions happening on the 6th of November, employers across the nation have an opportunity...

You May Also Like


Having a good Instagram marketing agency to back up your Instagram account is an absolute must going into the new year. With competition stronger...


The minute that any question pops into your head, you can simply ask Google. No longer do we have to pour over books and...


Insomnia is the most common sleep disorder in the global population. Therefore, it is a problem that many people suffer or have suffered throughout...


Ivermectin, an existing drug against parasites including head lice, has had a checkered history when it comes to treating COVID-19. The bulk of studies...

Disclaimer:, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 SmartRetirementReport. All Rights Reserved.